Market Cap 432.87M
Revenue (ttm) 303.91M
Net Income (ttm) -184.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -60.66%
Debt to Equity Ratio 0.00
Volume 620,655
Avg Vol 517,960
Day's Range N/A - N/A
Shares Out 40.61M
Stochastic %K 26%
Beta 0.62
Analysts Strong Sell
Price Target $15.67

Company Profile

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes A...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 518 795 1400
Address:
14 Plaza Drive, Latham, United States
Zeit59
Zeit59 Jun. 10 at 4:19 PM
$ANGO don't own it but I think it could be setting up for a break out. Thoughts?
0 · Reply
TalkMarkets
TalkMarkets Jun. 8 at 7:20 PM
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom $ANGO $ITGR $PEN https://talkmarkets.com/content/stocks--equities/3-medical-instruments-stocks-winning-big-with-genai-amid-global-gloom?post=501843&userid=123969
0 · Reply
SuperCoach
SuperCoach Jun. 6 at 9:53 PM
$ANGO I’M NOT SELLING!!!!
0 · Reply
BullsOnPrade
BullsOnPrade Jun. 6 at 12:00 PM
$ANGO snack time boyee
0 · Reply
Doozio
Doozio Jun. 3 at 6:43 PM
$ANGO like MNDY 🐑 🎁 s off da huckleberries!
0 · Reply
Doozio
Doozio May. 29 at 12:46 PM
$ANGO pullbacks into da huckleberries are a 🎁 during 🐒🍌🧠⏰♾️
0 · Reply
jotu
jotu May. 29 at 12:16 PM
$ANGO $25M loan https://investors.angiodynamics.com/sec-filings/sec-filing/8-k/0001140361-25-020621
0 · Reply
stockpicker63
stockpicker63 May. 28 at 2:16 PM
Watch now $ANGO
0 · Reply
garygb
garygb May. 26 at 7:31 PM
$ANGO Timing is everything.
0 · Reply
crtlabz
crtlabz Apr. 29 at 11:39 AM
$ANGO back to $7's
0 · Reply
Latest News on ANGO
AngioDynamics, Inc. (ANGO) Q3 2025 Earnings Call Transcript

Apr 2, 2025, 10:20 AM EDT - 2 months ago

AngioDynamics, Inc. (ANGO) Q3 2025 Earnings Call Transcript


AngioDynamics to Host Virtual Cardiovascular Investor Event

Mar 31, 2025, 8:00 AM EDT - 2 months ago

AngioDynamics to Host Virtual Cardiovascular Investor Event


AngioDynamics: A Surgical Approach To Market Growth

Jan 8, 2025, 5:15 PM EST - 5 months ago

AngioDynamics: A Surgical Approach To Market Growth


AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript

Jan 8, 2025, 11:00 AM EST - 5 months ago

AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript

Oct 3, 2024, 10:29 AM EDT - 9 months ago

AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript


AngioDynamics to Participate in Upcoming Investor Conferences

Jul 29, 2024, 4:15 PM EDT - 11 months ago

AngioDynamics to Participate in Upcoming Investor Conferences


AngioDynamics: Lumpy Progress Is Still Progress

Jul 17, 2024, 3:16 PM EDT - 11 months ago

AngioDynamics: Lumpy Progress Is Still Progress


AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript

Jul 16, 2024, 10:35 AM EDT - 11 months ago

AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript


A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 9, 2024, 4:49 PM EDT - 1 year ago

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story


AngioDynamics (ANGO) Q3 2024 Earnings Call Transcript

Apr 4, 2024, 11:11 AM EDT - 1 year ago

AngioDynamics (ANGO) Q3 2024 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q2 2024 Earnings Call Transcript

Jan 5, 2024, 10:26 AM EST - 1 year ago

AngioDynamics, Inc. (ANGO) Q2 2024 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q1 2024 Earnings Call Transcript

Oct 4, 2023, 10:35 AM EDT - 1 year ago

AngioDynamics, Inc. (ANGO) Q1 2024 Earnings Call Transcript


Zeit59
Zeit59 Jun. 10 at 4:19 PM
$ANGO don't own it but I think it could be setting up for a break out. Thoughts?
0 · Reply
TalkMarkets
TalkMarkets Jun. 8 at 7:20 PM
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom $ANGO $ITGR $PEN https://talkmarkets.com/content/stocks--equities/3-medical-instruments-stocks-winning-big-with-genai-amid-global-gloom?post=501843&userid=123969
0 · Reply
SuperCoach
SuperCoach Jun. 6 at 9:53 PM
$ANGO I’M NOT SELLING!!!!
0 · Reply
BullsOnPrade
BullsOnPrade Jun. 6 at 12:00 PM
$ANGO snack time boyee
0 · Reply
Doozio
Doozio Jun. 3 at 6:43 PM
$ANGO like MNDY 🐑 🎁 s off da huckleberries!
0 · Reply
Doozio
Doozio May. 29 at 12:46 PM
$ANGO pullbacks into da huckleberries are a 🎁 during 🐒🍌🧠⏰♾️
0 · Reply
jotu
jotu May. 29 at 12:16 PM
$ANGO $25M loan https://investors.angiodynamics.com/sec-filings/sec-filing/8-k/0001140361-25-020621
0 · Reply
stockpicker63
stockpicker63 May. 28 at 2:16 PM
Watch now $ANGO
0 · Reply
garygb
garygb May. 26 at 7:31 PM
$ANGO Timing is everything.
0 · Reply
crtlabz
crtlabz Apr. 29 at 11:39 AM
$ANGO back to $7's
0 · Reply
Doozio
Doozio Apr. 26 at 3:47 PM
$ANGO Roger has room to run on eps out of 🐑⏰♾️ because NOW they have started to PEGA da greed INTA 🐒🍌🧠⏰♾️
0 · Reply
Estimize
Estimize Apr. 21 at 2:06 PM
Wall St is expecting -0.12 EPS for $ANGO Q4 [Reporting 07/09 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
0 · Reply
BioGem
BioGem Apr. 11 at 5:29 AM
$ANGO Took a position at $9, many positives: -Undervalued on DCF and multiples. -High quality Exec and BOD: awards are related to stock performance and net income. -High CEO ownership of stock 7x base salary. -Re-structuring of Co since 2024 was achieved smoothly. -Beat and raised guidance for 2025. -Steady revenue growth in Med Tech segment. -Costs are in check and manufacturing to become cheaper = operating leverage = profits in sight and free cash flow positive soon. -Strong balance sheet, all debt paid off. -Stock buy backs in place. -Strong catalyst of Nanoknife with upcoming CPT code and insurance approvals. $XBI $IHI
0 · Reply
Jigajack1
Jigajack1 Apr. 10 at 10:36 AM
$ANGO pre market looking good
0 · Reply
Estimize
Estimize Apr. 10 at 10:03 AM
Wall St is expecting -0.12 EPS for $ANGO Q4 [Reporting 07/09 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
0 · Reply
TraderTimes
TraderTimes Apr. 8 at 12:42 PM
$ANGO: AngioDynamics is likely to quickly reach its all-time high in a favorable market environment https://t.co/pHKqQwcUff
0 · Reply
JarvisFlow
JarvisFlow Apr. 7 at 11:30 AM
HC Wainwright & Co. updates rating for AngioDynamics ( $ANGO ) to Buy, target set at 15 → 16.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Apr. 3 at 10:25 AM
WATCHLIST APR 03 2025. $ANGO Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance $ALT Citizens Capital Markets Reiterates Market Outperform on Altimmune, Maintains $25 Price Target $VSH The Optoelectronics Group of Vishay Intertechnology Introduces The Industry's First AEC-Q100 Qualified RGBIR Color Sensor $CRVO CervoMed shares are trading higher after the company announced it will present new data on Neflamapimod's impact on DLB. $NVAX Novavax Confirms That April 1, 2025, Was The U.S. FDA's Prescription Drug User Fee Act Date For It's Biologics License Application Seeking The Approval Its COVID-19 Vaccine
0 · Reply
JazzyJ03
JazzyJ03 Apr. 2 at 9:15 PM
$ANGO What is this ANGO? Checking it out.
1 · Reply
sam92
sam92 Apr. 2 at 3:57 PM
$ANGO $ISRG $BSX Worth taking a look ! $$$ Early stage grower Angio Dynamics Fiscal Year 2025 Financial Guidance ANGO For fiscal year 2025: The Company now expects net sales to be in the range of $285 to $288 million, up from previously issued guidance of $282 to $288 million, representing growth between 5.3% to 6.4% over fiscal 2024 pro forma revenue of $270.7 million The Company now expects Med Tech net sales to grow in the range of 14% to 16%, an increase from prior guidance of 12% to 15%
0 · Reply
jParkz
jParkz Apr. 2 at 3:30 PM
$ANGO News out AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results https://marketwirenews.com/news-releases/angiodynamics-reports-fiscal-year-2025-third-quarter-5957966478409423.html $ANGO
0 · Reply
prismmarketview
prismmarketview Apr. 2 at 2:56 PM
$ANGO #AngioDynamics #StocksOnTheMove #StocksInNews #investors #daytrader #PRISMMediaWire #PRISMDigitalMedia #StocksOnTheMove #StocksInNews #investors #daytrader #PRISMMediaWire #PRISMDigitalMedia https://prismmarketview.com/angiodynamics-shares-rise-on-strong-third-quarter-growth-and-increased-fiscal-2025-guidance/
0 · Reply